These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31275886)

  • 1. Rationale of family medicine physicians in effectively identifying patients with chronic hyperglycemia through point-of-care hemoglobin A1C screenings.
    Whitley HP; Hanson C; Parton JM; Smith WD
    J Diabetes Metab Disord; 2019 Jun; 18(1):155-162. PubMed ID: 31275886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic Diabetes Screening Using Point-of-Care HbA
    Whitley HP; Hanson C; Parton JM
    Ann Fam Med; 2017 Mar; 15(2):162-164. PubMed ID: 28289117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing point-of-care A1C and random plasma glucose for screening diabetes in migrant farm workers.
    Wensil AM; Smith JD; Pound MW; Herring C
    J Am Pharm Assoc (2003); 2013; 53(3):261-6. PubMed ID: 23699674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for diabetes risk using the diabetes risk test and point-of-care hemoglobin A1C values in adults seen in a dental clinic.
    Zelig R; Samavat H; Duda P; Singer S; Feldman C; LaSalle P; Muhammad E; Touger-Decker R
    Quintessence Int; 2023 Jun; 54(6):500-509. PubMed ID: 36917464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening test characteristics and comparison of diabetes outcomes among pregnant patients with prediabetes.
    Wilkie GL; Delpapa E; Leftwich HK
    J Obstet Gynaecol; 2022 Nov; 42(8):3498-3502. PubMed ID: 36448554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High Prevalence of Undiagnosed Hyperglycemia in Low-Income Overweight and Obese Hispanic Women in Oregon.
    Lindberg NM; Vega-López S; LeBlanc ES; Leo MC; Stevens VJ; Gille S; Arias-Gastélum M; Shuster E; Meenan R; Vaughn KA; Shaw MC; Turner A
    J Racial Ethn Health Disparities; 2019 Aug; 6(4):799-805. PubMed ID: 30859515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demographic and Clinical Profiles of Type 2 Diabetes Mellitus Patients Initiating Canagliflozin Versus DPP-4 Inhibitors in a Large U.S. Managed Care Population.
    Grabner M; Peng X; Geremakis C; Bae J
    J Manag Care Spec Pharm; 2015 Dec; 21(12):1204-12. PubMed ID: 26679969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediabetes Knowledge, Attitudes, and Practices at an Academic Family Medicine Practice.
    Keck JW; Thomas AR; Hieronymus L; Roper KL
    J Am Board Fam Med; 2019; 32(4):505-512. PubMed ID: 31300570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediabetes and Diabetes Screening in Dental Care Settings: NHANES 2013 to 2016.
    Estrich CG; Araujo MWB; Lipman RD
    JDR Clin Trans Res; 2019 Jan; 4(1):76-85. PubMed ID: 30596147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin A1c testing in an emergency department.
    Magee MF; Nassar C
    J Diabetes Sci Technol; 2011 Nov; 5(6):1437-43. PubMed ID: 22226261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examination of Prediabetes and Diabetes Testing Among US Pediatric Patients With Overweight or Obesity Using an Electronic Health Record.
    Belay B; Kraus EM; Porter R; Pierce SL; Kompaniyets L; Lundeen EA; Imperatore G; Blanck HM; Goodman AB
    Child Obes; 2024 Mar; 20(2):96-106. PubMed ID: 36930745
    [No Abstract]   [Full Text] [Related]  

  • 12. Longitudinal Observation of Outcomes and Patient Access to Integrated Care Following Point-of-Care Glycemic Screening in Community Health Center Dental Safety Net Clinics.
    Glurich I; Berg R; Panny A; Shimpi N; Steinmetz A; Nycz G; Acharya A
    Front Oral Health; 2021; 2():670355. PubMed ID: 35048014
    [No Abstract]   [Full Text] [Related]  

  • 13. PERFORMANCE OF A1C VERSUS OGTT FOR THE DIAGNOSIS OF PREDIABETES IN A COMMUNITY-BASED SCREENING.
    Camacho JE; Shah VO; Schrader R; Wong CS; Burge MR
    Endocr Pract; 2016 Nov; 22(11):1288-1295. PubMed ID: 27482613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
    Kennedy L; Herman WH; Strange P; Harris A;
    Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy and the Proper Use of the Point-of-Care Analysis in Hemoglobin A1C Measurement.
    Lynn L; Kay D; Younes N; Sen S; Jain V
    Metab Syndr Relat Disord; 2018 Apr; 16(3):117-121. PubMed ID: 29406816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and Impact of Unknown Diabetes in the ICU.
    Carpenter DL; Gregg SR; Xu K; Buchman TG; Coopersmith CM
    Crit Care Med; 2015 Dec; 43(12):e541-50. PubMed ID: 26465219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness of Point-of-Care A1C Tests in a Primary Care Setting.
    Rosa LS; Mistro S; Oliveira MG; Kochergin CN; Cortes ML; de Medeiros DS; Soares DA; Louzado JA; Silva KO; Bezerra VM; Amorim WW; Barone M; Passos LC
    Front Pharmacol; 2020; 11():588309. PubMed ID: 33542687
    [No Abstract]   [Full Text] [Related]  

  • 18. Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study).
    Kennedy L; Herman WH;
    Diabetes Technol Ther; 2005 Dec; 7(6):907-12. PubMed ID: 16386096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal Glycated Hemoglobin Cutoff Point for Diagnosis of Type 2 Diabetes in Iranian Adults.
    Razi F; Khashayar P; Ghodssi-Ghassemabadi R; Mehrabzadeh M; Peimani M; Bandarian F; Nasli-Esfahani E
    Can J Diabetes; 2018 Dec; 42(6):582-587. PubMed ID: 30007767
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.